Tag: Attention Deficit Hyperactivity Disorder

FDA refuses to approve Sunovion ADHD drug dasotraline

pharmanewsdaily- September 2, 2018

FDA decision on Sunovion ADHD drug approval : The US Food and Drug Administration (FDA) has refused to approve Sunovion Pharmaceuticals’ dual-acting dopamine and norepinephrine ... Read More

FDA okays NDA resubmission of Ironshore ADHD drug HLD200

pharmanewsdaily- July 15, 2018

Ironshore ADHD drug HLD200 : The US Food and Drug Administration (FDA) has accepted Ironshore Pharmaceuticals & Development’s resubmission of the New Drug Application (NDA) ... Read More